Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Aetna Inc    AET

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Goldman M&A head Sykes joins management committee

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/19/2012 | 11:07pm CET

Gene Sykes, global head of Goldman Sachs Group Inc's (>> Goldman Sachs Group, Inc.) mergers and acquisitions business, has been named to the investment bank's management committee, according to an internal memo.

Gene Sykes, global head of Goldman Sachs Group Inc's (>> Goldman Sachs Group, Inc.) mergers and acquisitions business, has been named to the investment bank's management committee, according to an internal memo.

The 54-year-old investment banker joins 28 other executives on the powerful committee, which includes Chief Executive Lloyd Blankfein and Chief Operating Officer Gary Cohn, and influences decisions about Goldman's business strategy and operations.

Sykes' appointment comes just nine days after the departure of another prominent Goldman banker, Yoel Zaoui, was announced in a separate internal memo. Zaoui shared the title of M&A co-head with Sykes and had also been on the management committee.

Sykes, who is based in Los Angeles, is also chairman of the global technology, media and telecommunications department of the investment banking division. He is a member of Goldman's internal Business Standards Committee.

The Goldman veteran joined the firm in 1984 and became a partner in 1992. He has advised on several high-profile deals, including Walt Disney Co's (>> The Walt Disney Company) acquisition of Pixar, Aetna Inc's (>> Aetna Inc.) acquisition of U.S. Healthcare and Roche Holding AG acquisition of Genentech.

"Gene has played a vital role in strengthening our investment banking franchise, particularly with respect to many of the most significant companies in technology and media," Blankfein and Cohn said in the memo, whose contents were confirmed by a spokesman.

(Reporting By Lauren Tara LaCapra in New York; editing by Andre Grenon)

By Lauren Tara LaCapra

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on AETNA INC
12/05DJAetna and Humana Argue a Merger's Benefits as Antitrust Trial Begins
12/05 AETNA : Declares Dividend of $0.2500.
12/02 AETNA : Board of Directors Declares Quarterly Cash Dividend
11/30 AETNA : Premier Care Network Plus Helps Reduce Costs for National Employers and ..
11/23 AETNA : Blue Edge Capital Lowers stake in Aetna Inc
11/22 AETNA INC. (NYSE : AET) Files An 8-K Entry into a Material Definitive Agreement
11/22 AETNA INC /PA/ : Entry into a Material Definitive Agreement, Creation of a Direc..
11/18 AETNA : New Holder Gruss Capital Management LP Has Trimmed Position
11/15 AETNA : Urges Medicare Beneficiaries to Shop and Save for 2017 -- Before Decembe..
11/10 Trump victory clouds outlook for Time Warner-AT&T, other mergers
More news
Sector news : Managed Healthcare - NEC
12/05DJAetna and Humana Argue a Merger's Benefits as Antitrust Trial Begins
11/30DJANTHEM : Begins Defense of Cigna Merger at Antitrust Trial
11/29DJU.S. Stocks Edge Higher
11/29DJANTHEM : Testimony Shows Anthem and Cigna at Odds Over Proposed Merger -- Update
11/29DJUNITEDHEALTH : Gives Upbeat Outlook for 2017
More sector news : Managed Healthcare - NEC
News from SeekingAlpha
12/06 Microsoft Defeats Salesforce; LinkedIn Deal Set To Close
12/05 J&J Target Offers Over 20% Upside
12/05 WALL STREET BREAKFAST : Investors Shrug Off Italy's Referendum Result
12/05 DOJ challenges Aetna-Humana deal
12/02 Aetna declares $0.25 dividend
Advertisement
Financials ($)
Sales 2016 63 143 M
EBIT 2016 4 909 M
Net income 2016 2 602 M
Debt 2016 4 521 M
Yield 2016 0,78%
P/E ratio 2016 17,66
P/E ratio 2017 15,84
EV / Sales 2016 0,79x
EV / Sales 2017 0,77x
Capitalization 45 105 M
More Financials
Chart AETNA INC
Duration : Period :
Aetna Inc Technical Analysis Chart | AET | US00817Y1082 | 4-Traders
Full-screen chart
Technical analysis trends AETNA INC
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Average target price 137 $
Spread / Average Target 6,4%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Mark T. Bertolini Chairman & Chief Executive Officer
Karen S. Lynch President
Margaret M. McCarthy Executive Vice President-Operations & Technology
Shawn M. Guertin CFO, Executive VP & Chief Enterprise Risk Officer
Harold L. Paz Chief Medical Officer & Executive Vice President
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
AETNA INC18.89%45 105
UNITEDHEALTH GROUP INC33.73%149 740
ANTHEM INC2.95%37 816
CIGNA CORPORATION-6.21%35 237
HUMANA INC14.45%30 461
CENTENE CORP-14.01%9 671
More Results